Continuous-infusion penicillin home-based therapy for serious infections due to penicillin-susceptible pathogens

International Journal of Antimicrobial Agents

Volumn 29, Issue 5, 2007, Pages 544-548

  Walton, Aaron L ^a   Howden, Benjamin P ^b,c   Grayson, Lindsay M ^b,c,d   Korman, Tony M ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b AUSTIN HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Bacterial infections; Infusions; Intravenous; Outpatient parenteral antibiotic therapy; Penicillin G

Indexed keywords

PENICILLIN G;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CATHETER INFECTION; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG DELIVERY SYSTEM; FEMALE; FEVER; HOME CARE; HUMAN; MALE; PENICILLIN ALLERGY; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG HYPERSENSITIVITY; FEMALE; HOME INFUSION THERAPY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN G;

EID: 34147093336     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.10.018     Document Type: Article

References (22)

1. Visser L.G., Arnouts P., van Furth R., et al. Continuous infusion of beta-lactam antibiotics: a rational dosing approach. Conn Med 59 (1995) 471-474
2. Visser L.G., Arnouts P., van Furth R., Mattie H., and van den Broek P.J. Clinical pharmacokinetics of continuous intravenous administration of penicillins. Clin Infect Dis 17 (1993) 491-495
3. Turnidge J.D. The pharmacodynamics of beta-lactams. Clin Infect Dis 27 (1998) 10-22
4. Craig W.A., and Ebert S.C. Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother 36 (1992) 2577-2583
5. Bayer A.S., and Scheld W.M. Endocarditis and intravascular infections. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases. 5th ed. vol. 1 (2000), Churchill Livingstone, Philadelphia, PA 857-902
6. Leder K., Turnidge J.D., Korman T.M., and Grayson M.L. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis. J Antimicrob Chemother 43 (1999) 113-118
7. Howden B.P., and Richards M.J. The efficacy of continuous infusion flucloxacillin in home therapy for serious staphylococcal infections and cellulitis. J Antimicrob Chemother 48 (2001) 311-314
8. Bakker-Woudenberg I.A., van den Berg J.C., Fontijne P., and Michel M.F. Efficacy of continuous versus intermittent administration of penicillin G in Streptococcus pneumoniae pneumonia in normal and immunodeficient rats. Eur J Clin Microbiol 3 (1984) 131-135
9. Bryan C.S., Talwani R., and Stinson M.S. Penicillin dosing for pneumococcal pneumonia. Chest 112 (1997) 1657-1664
10. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6 (2004), NCCLS, Wayne, PA
11. van Gulpen C., Brokerhof A.W., van der Kaay M., Tjaden U.R., and Mattie H. Determination of penicillin G and probenecid in human body fluids by high-performance liquid chromatography. J Chromatogr 381 (1986) 365-372
12. Vondracek T.G. Beta-lactam antibiotics: is continuous infusion the preferred method of administration?. Ann Pharmacother 29 (1995) 415-424
13. LeBel M., and Spino M. Pulse dosing versus continuous infusion of antibiotics. Pharmacokinetic-pharmacodynamic considerations. Clin Pharmacokinet 14 (1988) 71-95
14. Vinks A.A., Brimicombe R.W., Heijerman H.G., and Bakker W. Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokinetics. J Antimicrob Chemother 40 (1997) 125-133
15. Eagle H., Fleischman R., and Levy M. "Continuous" vs "discontinuous" therapy with penicillin: the effect of the interval between injections on therapeutic efficacy. N Engl J Med 248 (1953) 481-488
16. Wilson W.R., Karchmer A.W., Dajani A.S., et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 274 (1995) 1706-1713
17. Vella-Brincat J.W., Begg E.J., Gallagher K., et al. Stability of penicillin G during continuous home intravenous therapy. J Antimicrob Chemother 53 (2004) 675-677
18. Cardella J.F., Cardella K., Bacci N., Fox P.S., and Post J.H. Cumulative experience with 1,273 peripherally inserted central catheters at a single institution. J Vasc Interv Radiol 7 (1996) 5-13
19. Skiest D.J., Abbott M., and Keiser P. Peripherally inserted central catheters in patients with AIDS are associated with a low infection rate. Clin Infect Dis 30 (2000) 949-952
20. Moellering R.C. Enterococcus species, Streptococcus bovis, and Leuconostoc species. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases. 5th ed. vol. 2 (2000), Churchill Livingstone, Philadelphia, PA 2147-2156
21. Hof H., Nichterlein T., and Kretschmar M. Management of listeriosis. Clin Microbiol Rev 10 (1997) 345-357
22. Devereaux B.M., Crawford D.H., Purcell P., Powell L.W., and Roeser H.P. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?. Eur J Clin Pharmacol 49 (1995) 81-85